Biotech Firm Succeeds in Key Trial, Prescribes 310% Gains

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.

Markets

On Monday, U.S. equities recovered from earlier losses, with the benchmark indices closing higher despite renewed tensions between the U.S. and China.

Market-Moving News

Pharma

DNA Deal of the Year? Regeneron Secures 23andMe’s Data in $256M Bid

Regeneron (NASDAQ: REGN) is acquiring bankrupt genetic testing firm 23andMe for $256 million, a move that brings over 15 million DNA profiles under its control and shifts the spotlight to how biotech giants will use consumer genomics in R&D.

The acquisition excludes 23andMe’s telehealth arm but includes its direct-to-consumer testing business, which once led the ancestry craze before falling into decline after a 2023 data breach. Regeneron plans to keep existing privacy protections in place and will submit to oversight from a court-appointed reviewer.

This is a calculated risk, one that grants Regeneron access to one of the world's largest consumer DNA databases. If executed well, the data could shorten discovery cycles and personalize drug development at scale. Privacy controversies remain, but the real prize is long-term scientific advantage.

For long-term holders, this isn’t just about near-term gains. It’s a strategic bet on where medicine is headed: the intersection of AI and genomics. By acquiring 23andMe’s DNA library, Regeneron is building an asset that could fuel drug discovery pipelines for the next decade. As the pharmaceutical industry shifts toward personalized treatments, this trove of genetic data could become one of the most valuable tools in the field.

The court is scheduled to review the transaction on June 17. If approved, 23andMe will become a wholly owned unit of Regeneron by Q3.

U.S. AI Surge (Sponsored)

The AI Trade War Is Creating Winners

As U.S.-China trade tensions rise, chip exports are being restricted—and big names like Nvidia could face major revenue hits.

But this disruption is creating space for U.S.-based AI companies with strong domestic operations and rapid revenue growth.

A new report reveals 9 under-the-radar AI stocks poised to benefit from this shift.

Download the full list today—free for a limited time.

Access the “Top 9 AI Stocks for This Month” Now

Media

Magic Fades: Disney Slashes Jobs to Keep Streaming Dream Alive

Walt Disney Co. (NYSE: DIS) has laid off several hundred employees worldwide as part of ongoing cost-cutting and restructuring efforts tied to its strategic shift toward streaming.

Affected departments include film and TV marketing, publicity, casting, development, and corporate financial operations. While no entire team was dissolved, individual roles were eliminated, and employees were notified on Monday.

This move extends a broader strategy first outlined in 2023 by returning CEO Bob Iger, which included eliminating 7,000 roles across phases. In March, Disney also cut around 200 jobs at ABC News and its entertainment networks.

For long-term investors, this isn’t just about headcount. It signals Disney’s urgency in finding operational discipline as it doubles down on Disney+ and other digital platforms. The company’s linear TV business continues to shrink, and efficiency is becoming a survival skill, not just a management goal.

Globally, Disney employs over 230,000 people, with about 171,000 in the U.S. A company spokesperson said the changes are part of an ongoing effort to invest in core businesses while managing resources more effectively.

Investor attention will remain fixed on whether these cuts translate into measurable margin improvements in upcoming quarters, especially as competitors push harder in the streaming race.

Artificial Intelligence (Sponsored)

Top 5 Stocks for the AI Boom

AI’s capabilities are growing rapidly — handling layered conversations, correcting itself, and adapting in real time.

This shift is opening up new frontiers for early investors.

A free report just revealed 5 high-potential stocks—including one under-the-radar name with breakout potential.

These tickers are positioned to ride the AI boom in its most advanced form yet.

[See the Top 5 AI Stocks – Free Access]

Cloud Infrastructure

$7B Deal Signals Applied Digital's Comeback in AI Infrastructure

Applied Digital (NASDAQ: APLD) announced a pair of 15-year lease agreements with CoreWeave, a specialized cloud services firm backed by Nvidia, valued at roughly $7 billion over the term. The deal marks a major step in Applied Digital's evolution into a dedicated data center REIT focused on advanced compute workloads.

CoreWeave's rapid growth in AI cloud services has created a demand for scalable, power-dense infrastructure. By locking in this agreement, Applied Digital gains a highly visible revenue stream and validation of its long-term strategy to support next-generation computing.

For investors, this contract shows Applied Digital may be turning a critical corner. The guaranteed revenue helps smooth volatility in an otherwise capital-intensive sector and reflects the rising demand for alternative cloud infrastructure providers amid the expansion of AI. While the company is still navigating challenges, this deal helps reposition it as a serious player in hyperscale buildouts.

Infrastructure providers like Applied Digital stand to benefit as players like CoreWeave scale-out AI services using leased capacity rather than owning every layer. The shift favors firms able to deliver turnkey solutions, especially with chip access becoming a competitive bottleneck.

Lyra Therapeutics Inc [LYRA] $20.25 (+310.75%)

Lyra Therapeutics shares surged after its rhinosinusitis treatment passed a key Phase 3 trial, increasing chances for FDA approval.

Vera Therapeutics Inc [VERA] $31.74 (+67.49%)

Vera Therapeutics surged after a Phase 3 trial for its kidney disease drug showed a 46% reduction in proteinuria and a strong safety profile, potentially speeding up FDA approval.

Applied Digital Corp [APLD] $10.10 (+47.88%)

Applied Digital rallied after signing two long-term lease agreements with CoreWeave, securing $7 billion in revenue over 15 years and consolidating its role in the AI data infrastructure sector.

Sharplink Gaming Inc [SBET] $55.37 (-27.81%)

Sharplink Gaming has been highly volatile since announcing the $425 million private placement to acquire ETH. Although the deal was finalized today, the stock extended its correction, as the investment was already priced in.

Simulations Plus Inc [SLP] $26.35 (-17.26%)

Simulations Plus fell after announcing leadership changes and a restructuring plan involving a 10% reduction in its workforce.

Science Applications International [SAIC] $100.22 (-13.26%)

Science Applications International shares dropped after the company missed Q1 earnings expectations and issued full-year guidance below analyst estimates.

Q2 Market Movers (Sponsored)

Q2 Growth Playbook—Free Stock Picks Inside

Q2 2025 is heating up—and so are key growth opportunities in the market.

A newly released guide reveals 7 handpicked stocks with breakout potential based on sector momentum and earnings power.

These companies are positioned for strong moves as summer catalysts unfold.

It’s not hype—it’s a data-backed shortlist curated for impact.

Grab the “Top 7 Stocks for Q2 2025” Now

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.